Make your products visible globally with Elite Membership.
I agree to the terms and conditions
Existing User?
Sign In with Email
Remember Me Forgot Password?
New User?
Enter your registered Email ID to get reset password.
Elite Member
Individual Register
PASADENA, US: Jacobs Engineering Group announced that it has been awarded a contract from Solvay for a major, specialty polymers production plant to be built at Solvay’s industrial site in Changshu, Jiangsu province, China. Officials estimate the contract value to be approximately $9 million. Jacobs is executing the engineering, procurement and construction management (EPCM) services contract from its Shanghai operations in China.
Solvay is investing approximately $160 million in this plant, which will produce its products SOLEF PVDF and TECNOFLON FKM, as well as its essential VF2 monomer. The plant is scheduled to become operational in the first quarter of 2014 and is expected to significantly boost Solvay’s global production capacity for these specialty polymers. “We look forward to contribute to this large and significant project for Solvay, drawing upon our strong, sector-relevant technical and project management skills to support the project,” said Tom Quinn, Vice President, Jacobs.
© WOC News
Login
OHIO, US: Scientists have combined two new ‘designer’ forms of aspirin into a hybrid substance that appears more effective than either of ...
IOWA, US: According to Iowa State University research team, genetic mutations to cellulose in plants could improve the conversion of cellulosic biomas ...
OSLO, NORWAY: Yara has signed a heads of agreement with Orica and Apache for joint venture to build a 330,000 metric tonne ammonium nitrate plant on t ...
AMSTERDAM, THE NETHERLANDS: AkzoNobel announced a number of personnel changes in its governance structure. Two new supervisory board members will be n ...
SWINDON, UK: The Technology Strategy board (TSB) is to invest up to £5 million in feasibility projects and collaborative research and developmen ...
BASEL, SWITZERLAND/CALIFORNIA, US: Lonza and Eclipse Therapeutics announced an agreement for the production of Eclipse’s novel cancer therapeuti ...
Stay updated with the latest chemical industry trends and innovations.
Verification Code has been sent to
Please enter the Verification Code below to verify your Email Address.If you cannot see the email from "noreply@worldofchemicals.com" in your inbox,make sure to check your SPAM Folder